Three Reasons to Retain Avanos (AVNS) Stock in Your Portfolio [Yahoo! Finance]
DaVita Inc. (DVA)
Last davita inc. earnings: 2/10 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.davita.com/investor-relations
Company Research
Source: Yahoo! Finance
The optimism led by a solid fourth-quarter 2023 performance and continued focus on its research and development (R&D) are expected to contribute further. However, stiff competition and macroeconomic concerns persist. Over the past year, this Zacks Rank #3 (Hold) stock has lost 33.9% against the 9.8% rise of the industry and 27.6% growth of the S&P 500 Composite. The renowned medical device solutions provider has a market capitalization of $905.1 million. The company projects 12.4% growth for the next five years and expects to maintain its strong performance. Avanos' earnings yield of 7% compares favorably against the industry's negative yield. Image Source: Zacks Investment Research Let's delve deeper. Product Portfolio: Avanos' robust product suite raises our optimism. Digestive Health is a portfolio of products that includes its MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. Pain Management and Recovery
Show less
Read more
Impact Snapshot
Event Time:
DVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DVA alerts
High impacting DaVita Inc. news events
Weekly update
A roundup of the hottest topics
DVA
News
- Kidney Dialysis Market is expected to reach a revenue of USD 143.8 Bn by 2032, at 6.2% CAGR: Dimension Market Research [Yahoo! Finance]Yahoo! Finance
- DaVita Inc. (NYSE: DVA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- DaVita Inc. (NYSE: DVA) had its price target raised by analysts at Barclays PLC from $133.00 to $150.00. They now have an "equal weight" rating on the stock.MarketBeat
- DaVita HealthCare (DVA) is a Top-Ranked Value Stock: Should You Buy? [Yahoo! Finance]Yahoo! Finance
- Is DaVita (DVA) a Great Value Stock Right Now? [Yahoo! Finance]Yahoo! Finance
DVA
Earnings
- 5/2/24 - Beat
DVA
Sec Filings
- 5/2/24 - Form 10-Q
- 5/2/24 - Form 8-K
- 5/1/24 - Form 8-K
- DVA's page on the SEC website